Clinical Trial, Phase III
Also known asClinical Trial, Phase 3
Definition
Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the United States or a foreign country.
MeSH classification
- V03.175.250.300
Need clinical context, treatments, or patient-language explanation?
Ask GoDavaii AI about Clinical Trial, Phase IIIRelated concepts
Adaptive Clinical Trial
Clinical study in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data fro…
Clinical Trial
A work that reports on the results of a clinical study in which participants are assigned to receive one or more interventions so that resea…
Clinical Trial, Phase I
Work that is the report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or proph…
Clinical Trial, Phase II
Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophyl…
Clinical Trial, Phase IV
Work that is a report of a planned post-marketing study of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have …
Controlled Clinical Trial
A work that reports on a clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures fo…
Equivalence Trial
Trial that aims to show a new treatment is no better and no worse than the standard treatment.
Human Challenge Trials
Trials in which participants are intentionally challenged (whether or not they have been vaccinated) with exposure to an infectious disease …
Source: NIH MeSH 2026 (D017428) — National Library of Medicine, public domain. View official MeSH record ↗